Gashirai K Mbizvo

Feb 27, 2024 | onlinelibrary.wiley.com | Josephine Mayer |Liverpool John Moores |Liverpool Heart |Gashirai K Mbizvo

Lamotrigine was associated with reduced risk of adverse cardiovascular outcomes compared to carbamazepine and valproate Carbamazepine and valproate demonstrated similar cardiovascular event risk Prescribers should consider the impact of antiseizure medication choice on cardiovascular health in patients with epilepsy 1 INTRODUCTION People with epilepsy (PWE) have an increased risk of cardiovascular disease.1-4 There are several mechanisms underlying this relationship, including the causal...

Jun 12, 2023 | physiciansweekly.com | Tommaso Bucci |Gashirai K Mbizvo |José Miguel Rivera-Caravaca |Josephine Mayer

The risks of cardiovascular events(CVEs) in people with epilepsy(PWE) are not well understood. To establish the short- and long-term burden of CVEs in PWE. Electronic health records from a global federated health research network(TriNetX) were used to establish a cohort of PWE.